MGM Healthcare Chennai successfully treats a patient suffering with Gastroesophageal Reflux Disorders using GERD-X Applicator
MGM Healthcare Chennai successfully treats a patient suffering with Gastroesophageal Reflux Disorders using GERD-X Applicator for the first time in Tamil Nadu
~ Improves the quality of life and reduce the medications usage~
Chennai, 29th September 2022: MGM Healthcare, a multi-specialty quaternary care hospital in the heart of Ch ennai, today announced that it had successfully treated a patient suffering with Gastroesophageal reflux disease using GERD-X applicator – for the first time in Tamil Nadu. Gastroesophageal reflux disease (GERD) occurs when the valve loosens up and allows acid contents to move up into the esophagus. A multi-disciplinary team lead by Dr. Arul Prakash, Senior Consultant & Clinical Lead, Department of Medical Gastroenterology & Hepatology M GM Healthcare and Dr. Tarun John George – Associate Consultant- Gastroenterology and Hepatology MGM He althcare successfully conducted this procedure on the patient.
A 23-year-old female from Chennai was suffering from Gastroesophageal reflux disease (GERD). The patient re ached out to MGM Healthcare after performing lot of research and multiple consultations with the doctors from other hospitals. The young patient was not responding to antacids and acid reducing medication and thus was su ggested for GERD-X procedure (non-invasive procedure of tightening the food pipe junction under general Ana esthesia). The procedure is performed with a help of an endoscopic camera and non-absorbable suture system.
Speaking about the case, Dr. Arul Prakash, Senior Consultant & Clinical Lead, Department of Medical Gastroen terology & Hepatology MGM Healthcare and Dr Tarun John George– Associate Consultant- Gastroenterology and MGM Healthcare explained “It is estimated around 30% population of India suffer from gastroesophageal reflux disease. This young patient was suffering with the same problem and was not responding to antacids and acid reducing medication. We suggested the GERD-X applicator procedure to reduce the usage of medications, and this requires only a short period of hospitalization. Post evaluation of the condition of the patient, we had su ggested to go for this treatment and the procedure proved to be a successful one. This technique paves way to perform more similar procedures in future thereby simplifying the time taken in treating Gastroesophageal re flux disease.
On speaking about this procedure, Mr. Harish Manian, chief executive officer, MGM Healthcare says, “It is hea rtening to see technology paving the way for better clinical outcomes and shorter stays in hospitals. The GERD-X introduced at MGM Healthcare is an endeavor to ensure expertise is coupled with latest technology enabling better clinical customer and ensures lesser spend. This success forms a base for many more who suffer would be at ease with this kind of a condition.”
